Truehand Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Truehand Inc’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1K	Hold	166	–	–	﹤0.01%	188
2021 Q3	$2K	Hold	166	–	–	﹤0.01%	184
2021 Q2	$2K	Hold	166	–	–	﹤0.01%	188
2021 Q1	$2K	Hold	166	–	–	﹤0.01%	190
2020 Q4	$2K	Hold	166	–	–	﹤0.01%	206
2020 Q3	$1K	Hold	166	–	–	﹤0.01%	209
2020 Q2	$2K	Hold	166	–	–	﹤0.01%	201
2020 Q1	$1K	Hold	166	–	–	﹤0.01%	178
2019 Q4	$2K	Hold	166	–	–	﹤0.01%	173
2019 Q3	$1K	Hold	166	–	–	﹤0.01%	182
2019 Q2	$2K	Hold	166	–	–	﹤0.01%	177
2019 Q1	$3K	Hold	166	–	–	﹤0.01%	181
2018 Q4	$3K	Buy	+166	New	+$3.4K	﹤0.01%	184

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Truehand Inc's TEVA Position: Q4 2021 in Review

Truehand Inc held its Teva Pharmaceuticals (TEVA) position steady in Q4 2021 at 166 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #188.

Truehand Inc first reported a position in TEVA in Q4 2018 and has held it in 13 quarters since. The position peaked at $3K in Q1 2019. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

Truehand Inc held 166 shares of Teva Pharmaceuticals worth $1K as of Q4 2021.
Truehand Inc left its Teva Pharmaceuticals share count unchanged in Q4 2021.
Teva Pharmaceuticals made up ﹤0.01% of Truehand Inc's portfolio in Q4 2021, its #188 holding.
Truehand Inc first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 13 quarters since.
Truehand Inc's Teva Pharmaceuticals position peaked at $3K in Q1 2019.
450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Truehand Inc's 13F filing for Q4 2021, filed 9 Feb 2022.